ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. (“Company” or “Alliança”) (B3: AARL3), in compliance with the provisions of art. 157, § 4.º, of Law No. 6,404, of December 15, 1976, as amended (“Corporate Law”) and in CVM Resolution No. 44, of August 23, 2021, as amended, informs to its shareholders and the market in general that, in a meeting on September 27, 2024, the Company’s Board of Directors approved the following matters:
- the execution of an Advance Instrument for Future Capital Increase (“AFAC”) with its controlling shareholder, Lormont Participações S.A. (“Lormont”), on September 27, 2024, through which Lormont assumed the obligation to make, on this date, a new contribution to the Company in the amount of R$ 61,000,000.00 (sixty-one million reais); and
- authorize the members of the Company’s Board of Directors and/or their duly appointed attorneys to take all measures and perform all acts that are necessary to implement the resolution approved herein
This AFAC aims to improve the Company’s capital structure, allowing the continued implementation of its business and expansion plan, as well as the fulfillment of obligations already contracted.
São Paulo, September 27 2024.
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.